MEI Pharma (MEIP) Stock: Here’s What You Need To Know

MEI Pharma Inc. (NASDAQ:MEIP) On Monday, MEI pharma released results of its phase 2 clinical trial in elderly patients with Acute Myeloid Leukemia – AML. These results were presented at a prestigious medical conference known as the American Society of Hematology or ASH. The results themselves were outstanding, but the stock didn’t budge at all. … Read more

Durect Corp (DRRX) Stock: Here’s What You Need To Know

Durect Corp. (NASDAQ:DRRX) On Monday, Durect Corp stock fell by 32% after Pain Therapeutics (PTIE) received a Complete Response Letter — CRL — from the Food and Drug Administration — FDA. The drug that received the CRL is known as Remoxy ER, and was Pain’s drug obtained through a license from Durect Corp. The FDA … Read more

Raptor Pharmaceuticals (RPTP) Stock Bought Out: Here’s What You Need To Know

Raptor Pharmaceuticals (NASDAQ:RPTP) On Monday, Horizon Pharma bought out Raptor Pharmaceuticals for $800 million  in an all cash deal. Taking into account the amount of cash in the buyout, it translates to $9 per share. Although the stock traded higher by 20.3% to $8.96. Before the news of the announcement Raptor’s stock traded at $7.45 … Read more

Seres (MCRB) Stock: Here’s What You Need To Know

Seres Therapeutics (NASDAQ:MCRB) On Friday, Seres Therapeutics stock plummeted by 70% after the company reported that it had failed mid-stage trial in patients with Clostridium difficile infection or C. diff. The company has a big pipeline, but the problem is that the study that failed was the lead drug candidate. Thus, the reason why the … Read more

Biotech Stock News (CLVS)(SNTA)

Clovis Oncology (NASDAQ:CLVS) On Tuesday April 13, 2016 Clovis Oncology announced that the FDA advisory panel concluded that the company’s drug, Rociletinib, had insufficient data to warrant approval. Not only did the FDA panel advise against approval, it shot down the drug with a vote of 12 “against and 1 “for” approval. This was the … Read more

Biotech Stock News (AGN) (PFE) (ICPT)

Allergan (NYSE:ACT) & Pfizer (NYSE:PFE) On April 5, 2016 shares of Allergan had tumbled by 14.77% as investors had become skeptical that the deal with Pfizer would actually go through. The reason for  investors becoming skeptical was because the government had implemented new tax inversion rules. Back in November Pfizer brokered a deal to buy … Read more

Biotech Stock News (ACAD) (RXII) (REGN) (AZN) (ZSPH)

Acadia Pharmaceuticals (NASDAQ:ACAD) On November 3, 2015 Acadia had announced that the FDA had given its Parkinson’s Drug, NUPLAZID, FDA priority review. To understand what this means, we must first understand what the FDA priority review actually means? A company is only given FDA priority review if the drug it has developed treats an unmet … Read more

Biotech Stock News (AMGN) (RGLS) (BIIB) (RVNC) (AGN)

Amgen, Inc. (NASDAQ:AMGN) On October 28, 2015 Amgen had announced that it had received FDA approval for its skin cancer drug known as IMLYGIC. This drug is an injection type drug that helps boost the immune system to fight off and kill cancerous skin cells. This therapy only treats Melanoma — skin cancer– but does … Read more

MannKind Works To Move Up: Even The Bears Are Seeing Potential

MannKind Corporation (NASDAQ: MNKD) MannKind, like most other US stocks has been struggling through recent days pushing the stock to lows that we haven’t seen in quite some time. However, today the stock has stayed above the green line while struggling to maintain momentum. Although the bears are continuing their attempt to push the stock … Read more

Biotech Stock News (INO) (AZN) (IMUC) (AAVL) (REGN)

Inovio Pharmaceuticals (NASDAQ:INO) On August 10, 2015 shares of Inovio were up about 25% after the company announced a partnership deal with a big pharmaceutical company known as AstraZeneca (NYSE:AZN). Although one key thing to note here is that this deal is being established with MedImmune specifically, but it is the research and development arm for … Read more